about
Clinical and Electrophysiologic Responses to Acetylcholinesterase Inhibitors in MuSK-Antibody-Positive Myasthenia Gravis: Evidence for Cholinergic Neuromuscular HyperactivityThe significance of clinical and laboratory features in the diagnosis of glycogen storage disease type v: a case report.Whole-Body Muscle MRI in Patients with Hyperkalemic Periodic Paralysis Carrying the SCN4A Mutation T704M: Evidence for Chronic Progressive Myopathy with Selective Muscle InvolvementClinical and Pathological Heterogeneity of Korean Patients with CAPN3 MutationsFirst Identification of Compound Heterozygous FKRP Mutations in a Korean Patient with Limb-Girdle Muscular DystrophyThe Epidemiology of Myasthenia Gravis in Korea.Clinical characteristics and molecular genetic analysis of Korean patients with GNE myopathyClinical Significance of Repetitive Compound Muscle Action Potentials in Patients with Myasthenia Gravis: A Predictor for Cholinergic Side Effects of Acetylcholinesterase Inhibitors.The role of insulin resistance in diabetic neuropathy in Koreans with type 2 diabetes mellitus: a 6-year follow-up study.Clinical and genetic aspects in twelve Korean patients with adrenomyeloneuropathy.Whole-genome analysis in Korean patients with autoimmune myasthenia gravis.Volume-based quantification using dual-energy computed tomography in the differentiation of thymic epithelial tumours: an initial experience.Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia GravisLow D4Z4 copy number and gender difference in Korean patients with facioscapulohumeral muscular dystrophy type 1.Clinical and Pathological Findings of a Korean Family with Pathogenic Variants of the TTN Gene.Clinical, Pathologic, and Genetic Features of Collagen VI-Related Myopathy in Korea.The Impacts of Influenza Infection and Vaccination on Exacerbation of Myasthenia Gravis.Clinical and electromyographic features of radiation-induced lower cranial neuropathy.Targeted next-generation sequencing for the genetic diagnosis of dysferlinopathy.Clinical and Pathologic Findings of Korean Patients with RYR1-Related Congenital Myopathy.Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer.Partial Conduction Block as an Early Nerve Conduction Finding in Neurolymphomatosis.FAT1 Gene Alteration in Facioscapulohumeral Muscular Dystrophy Type 1.Distal myopathy with ADSSL1 mutations in Korean patients.Discovery of pathogenic variants in a large Korean cohort of inherited muscular disorders.Juvenile Myasthenia Gravis in Korea: Subgroup Analysis According to Sex and Onset Age.Paraneoplastic Neuromyelitis Optica Associated with Lung Adenocarcinoma in a Young Woman.Predictive factors for myasthenic crisis after videoscopic thymectomy in patients with myasthenia gravisSpinal cord involvement in Behçet's diseaseClinical and laboratory features of patients with osteomalacia initially presenting with neurological manifestationsRisk factors for osteoporosis in chronic inflammatory demyelinating polyradiculoneuropathyClinical and Radiographic Characteristics of Neuro-Behçet's Disease in South KoreaA prospective randomized trial of continuous paravertebral infusion versus intravenous patient-controlled analgesia after thoracoscopic lobectomy for lung cancerUnusual cortical involvement in aquaporin-4 antibody-positive patients: An analysis with double inversion recovery and phase-sensitive inversion recovery imagingSerum CXCL13 reflects local B-cell mediated inflammatory demyelinating peripheral neuropathyLower-extremity magnetic resonance imaging in patients with hyperkalemic periodic paralysis carrying the SCN4A mutation T704M: 30-month follow-up of seven patientsEffect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravisComparative transcriptome analysis of skeletal muscle in ADSSL1 myopathyRisk of osteoporosis in patients with chronic inflammatory neuropathy- a population-based cohort studyLong-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
P50
Q33594748-1CDD1334-180A-492D-AB0A-A00294DF0BD7Q33913661-180EA770-0580-4562-B9D5-5F17C7BC60FCQ36130073-83A5C5AB-FC04-45BC-8EB8-DD49BEC81A0FQ36418689-B124F6E2-5E5B-4815-9C6C-1924BEAC62D9Q36460610-7A9C6178-CCDE-425A-A43C-DEA5B016A69CQ36541587-A079F986-2C04-437B-B0AF-E409894260D4Q36793171-6F595EA0-B9CD-4753-8800-A58198E9BED0Q37338714-227A9F97-41BF-4FA6-BD2E-6C04BFF4A1BFQ37708207-0089BEE4-8076-406D-B896-4CFDE9EFFF5CQ37708247-9F69BA6B-AFB3-48A9-8D04-E0ACB23A9644Q37708262-282C46D6-3A96-4675-A26B-83CDDE2683EBQ38935244-18D20DF5-BD00-42B9-9BE5-D39DFEBDDD9DQ41159458-F4504B5F-9048-48C0-B21E-EA257712B6DEQ41441233-F4E8BA98-6B1A-4C24-811C-B681D1E79AC6Q42329989-F20B4127-4988-4D13-94F9-176BC621B0E3Q42646168-F7EC15CC-7321-441A-810A-A3EAFEAC0224Q42646172-DDA9C574-BDA7-4589-98BF-AEBC045DE382Q44266935-CA6C42E6-6256-4498-BA6A-17EFEDF81D9AQ48232619-1A753CD7-CC03-4961-84C2-4995DAA77BA1Q49283604-59561ADD-1BC5-4D72-BA61-A09C8A4DB877Q49407705-654F9E82-D943-4B18-86D4-DA732A58DE2AQ49627290-90EAC672-CBAC-4101-A20C-CC302409FE94Q50049313-D58E86BC-158E-49D5-AA7C-6C37F8B633B7Q52895113-337DDA10-3575-4E98-8117-53FC34A43391Q53152323-311D14E7-8FF0-4767-903A-55624CF850B2Q53761765-68389B44-3BEC-49F0-8A73-FE3350F2E6BBQ55110037-39A51BB7-F2B0-45A2-BAF3-A40DF85BE472Q86177277-8EE4A0A6-5621-499F-B9FE-F0777494D3BCQ86512877-B38B143D-A33F-4AEA-A8F6-6BF3219E375DQ88288329-64C3CF4E-2B28-4A99-81BC-5C8F6C871D56Q89085651-78D04BB6-823A-4468-817D-99857D80A0EAQ90578747-FBC01D92-7A8E-4ACB-A3D8-A1B5F4F5ACC2Q90701723-CDBC3771-0988-450C-B9E3-C9D2C81DB825Q91031934-C3A23B9E-A4C0-4581-9AE8-E6FA00F846D2Q91235665-89EE4A4C-EE52-48A2-8EEE-719E3CA2EDF9Q91259078-EC243C80-DC6E-4233-AF6D-515EACA45DBFQ91379083-746767B5-B1B3-446C-8C12-1685E3DC6394Q92251107-71339A74-9161-4660-89B2-DFBA81A44F6FQ92999882-330B212C-9580-4540-81BA-20A196477C56Q93096191-8BBAD642-1BE3-4B32-8EDD-1E08644E3D35
P50
description
researcher ORCID ID = 0000-0002-4408-8265
@en
wetenschapper
@nl
name
Ha Young Shin
@ast
Ha Young Shin
@en
Ha Young Shin
@nl
type
label
Ha Young Shin
@ast
Ha Young Shin
@en
Ha Young Shin
@nl
prefLabel
Ha Young Shin
@ast
Ha Young Shin
@en
Ha Young Shin
@nl
P31
P496
0000-0002-4408-8265